Presima Securities ULC trimmed its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 16.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,009,181 shares of the real estate investment trust's stock after selling 198,841 shares during the period. Sabra Health Care REIT accounts for about 4.1% of Presima Securities ULC's investment portfolio, making the stock its 13th biggest holding. Presima Securities ULC owned approximately 0.43% of Sabra Health Care REIT worth $18,781,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of SBRA. Family Firm Inc. bought a new stake in shares of Sabra Health Care REIT during the second quarter worth approximately $26,000. GAMMA Investing LLC increased its stake in Sabra Health Care REIT by 40.0% in the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock valued at $57,000 after purchasing an additional 1,052 shares in the last quarter. Future Financial Wealth Managment LLC bought a new stake in Sabra Health Care REIT in the first quarter valued at approximately $89,000. Point72 Hong Kong Ltd bought a new stake in Sabra Health Care REIT in the second quarter valued at approximately $117,000. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in Sabra Health Care REIT in the second quarter valued at approximately $122,000. 99.40% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several brokerages have commented on SBRA. Citigroup raised shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and upped their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Scotiabank upped their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a research note on Friday, October 11th. Truist Financial upped their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Wednesday, September 4th. Finally, Wells Fargo & Company raised shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $18.11.
View Our Latest Analysis on SBRA
Sabra Health Care REIT Stock Down 1.1 %
Shares of SBRA stock traded down $0.21 during trading hours on Thursday, hitting $18.22. 940,171 shares of the company were exchanged, compared to its average volume of 2,025,635. Sabra Health Care REIT, Inc. has a 52 week low of $12.83 and a 52 week high of $19.32. The business has a 50 day moving average of $17.59 and a two-hundred day moving average of $15.79. The company has a market capitalization of $4.27 billion, a PE ratio of 87.76, a PEG ratio of 2.61 and a beta of 1.26. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.24). Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The business had revenue of $176.14 million for the quarter, compared to analyst estimates of $166.54 million. During the same quarter in the previous year, the company posted $0.34 EPS. The business's revenue for the quarter was up 9.3% compared to the same quarter last year. Analysts anticipate that Sabra Health Care REIT, Inc. will post 1.38 earnings per share for the current fiscal year.
Sabra Health Care REIT Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 19th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.59%. The ex-dividend date was Monday, August 19th. Sabra Health Care REIT's payout ratio is 571.43%.
Sabra Health Care REIT Profile
(
Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Recommended Stories
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.